A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV

Autor: Ndlangisa, K.M., du Plessis, M., Lo, S., de Gouveia, L., Chaguza, C., Antonio, M., Kwambana-Adams, B., Cornick, J., Everett, D.B., Dagan, R., Hawkins, P.A., Beall, B., Corso, A., Grassi Almeida, S.C., Ochoa Woodell, Theresa Jean, Obaro, S., Shakoor, S., Donkor, E.S., Gladstone, R.A., Ho, P.L., Paragi, M., Doiphode, S., Srifuengfung, S., Ford, R., Moïsi, J., Saha, S.K., Bigogo, G., Sigauque, B., Eser, ÖK., Elmdaghri, N., Titov, L., Turner, P., Kumar, K.L.R., Kandasamy, R., Egorova, E., Ip, M., Breiman, R.F., Klugman, K.P., McGee, L., Bentley, S.D., von Gottberg, A., The Global Pneumococcal Sequencing Consortium

Pneumococcal serotype 35B is an important non-conjugate vaccine (non-PCV) serotype. Its continued emergence, post-PCV7 in the USA, was associated with expansion of a pre-existing 35B clone (clonal complex [CC] 558) along with post-PCV13 emergence of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ba7af37f228da33d514b36d37bb569
https://doi.org/10.1099/mgen.0.000746

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Autor: Gladstone, R.A., Siira, L., Brynildsrud, O.B., Vestrheim, D.F., Turner, P., Clarke, S.C., Srifuengfung, S., Ford, R., Lehmann, D., Egorova, E., Voropaeva, E., Haraldsson, G., Kristinsson, K.G., McGee, L., Breiman, R.F., Bentley, S.D., Sheppard, C.L., Fry, N.K., Corander, J., Toropainen, M., Steens, A., Akpaka, P.E., Ampofo, K., Antonio, M., Balaji, V., Beall, B.W., Belabbès, H., Benisty, R., Bigogo, G., Brooks, A.W., Carter, P.E., Cornick, J.E., Corso, A., Cristina de Cunto Brandileone, M., Cristine Grassi Almeida, S., Croucher, N.J., Dagan, R., Davydov, A., Diawara, I., Doiphode, S., du Plessis, M., Elmdaghri, N., Köseoglu Eser, Ö., Everett, D.B., Faccone, D., Gagetti, P., Givon-Lavi, N., Hasanuzzaman, M., Hawkins, P.A., Hryniewicz, W., Hulten, K.G., Ip, M., Kapusta, A., Kandasamy, R., Kastrin, T., Keenan, J., Klugman, K.P., Kwambana-Adams, B., Law, P.Y., Lees, J.A., Leung Ho, P., Li, Y., Lo, S.W., Ochoa Woodell, Theresa Jean, Madhi, S.A., Metcalf, B.J., Moïsi, J., Mucavele Fundação Manhiça, H., Ndlangisa, K.M., Nurse-Lucas, M., Nzenze, S.A., Obaro, S.K., Paragi, M., Pollard, A.J., Ravikumar, K.L., Sadowy, E., Saha, S.K., Sampane-Donkor, E., Devi Sekaran, S., Shakoor, S., Shrestha, S., Sigauque, B., Skoczynska, A., Soo ko, K., Tientcheu, P.-E., Titov, L., Urban, Y., Verani, J., van Tonder, A.J., von Gottberg, A., Wolter, N., The Global Pneumococcal Sequencing Consortium

Publikováno v: Vaccine

Background Pneumococcal disease outbreaks of vaccine preventable serotype 4 sequence type (ST)801 in shipyards have been reported in several countries. We aimed to use genomics to establish any international links between them. Methods Sequence data

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1fbf0583c8179561f1514e18e337159
https://hdl.handle.net/20.500.12866/11479

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Autor: Gladstone, Rebecca Ashley, Siira, Lotta, Brynildsrud, Ola Brønstad, Vestrheim, Didrik Frimann, Turner, Paul, Clarke, S.C., Srifuengfung, S., Ford, R., Lehmann, D., Egorova, E., Voropaeva, E., Haraldsson, G., Kristinsson, K.G., McGee, L., Breiman, Robert F., Bentley, S.D., Sheppard, Carmen L., Fry, N.K., Corander, Jukka, Toropainen, M., Steens, Anneke

Externí odkaz: https://hdl.handle.net/11250/2987816

A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV.

Autor: Ndlangisa KM; National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, Johannesburg, South Africa., du Plessis M; National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, Johannesburg, South Africa.; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., Lo S; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK., de Gouveia L; National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, Johannesburg, South Africa., Chaguza C; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK., Antonio M; WHO Collaborating Centre for New Vaccines Surveillance, Medical Research Council Unit, The Gambia at London School of Hygiene & Tropical Medicine, Fajara, The Gambia., Kwambana-Adams B; NIHR Global Health Research Unit on Mucosal Pathogens, Division of Infection and Immunity, University College London, London, UK.; West Africa Partnerships and Strategies, Medical Research Council Unit The Gambia at The London School of Hygiene and Tropical Medicine, Fajara, Gambia., Cornick J; Malawi-Liverpool-Wellcome-Trust, Blantyre, Malawi., Everett DB; Malawi-Liverpool-Wellcome-Trust, Blantyre, Malawi.; Centre for Inflammation Research, Queens Research Institute, University of Edinburgh, Edinburgh, UK., Dagan R; The Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel., Hawkins PA; Rollins School Public Health, Emory University, Atlanta, USA.; Centers for Disease Control and Prevention, Atlanta, USA., Beall B; Centers for Disease Control and Prevention, Atlanta, USA., Corso A; Administración Nacional de Laboratorios e Institutos de Salud, Buenos Aires, Argentina., Grassi Almeida SC; Center of Bacteriology, Adolfo Lutz Institute, São Paulo, Brazil., Ochoa TJ; Instituto de Medicina Tropical, Universidad Peruana Cayetano Heredia, Lima, Peru., Obaro S; University of Nebraska Medical Center, Omaha, USA., Shakoor S; The Aga Khan University, Karachi, Pakistan., Donkor ES; Department of Medical Microbiology, University of Ghana Medical School, Accra, Ghana., Gladstone RA; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK., Ho PL; Department of Microbiology and Carol Yu Centre for Infection, The University of Hong Kong, Queen Mary Hospital, Hong Kong, PR China., Paragi M; National Laboratory of Health, Environment and Food, Ljubljana, Slovenia., Doiphode S; Hamad Medical Corporation, Doha, Qatar., Srifuengfung S; Faculty of Pharmacy, Siam University, Bangkok, Thailand., Ford R; Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea., Moïsi J; Agence de Médecine Préventive, Paris, France., Saha SK; Child Health Research Foundation, Dhaka, Bangladesh., Bigogo G; Kenya Medical Research Institute, Kisumu, Kenya., Sigauque B; Centro de Investigação em Saúde da Manhiça, Maputo, Moçambique., Eser ÖK; Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey., Elmdaghri N; Faculty of Medicine and Pharmacy & Ibn Rochd University Hospital Center, Casablanca, Morocco., Titov L; The Republican Research and Practical Center for Epidemiology and Microbiology, Minsk, Belarus., Turner P; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK., Kumar KLR; Kempegowda Institute of Medical Sciences Hospital & Research Center, Bangalore, India., Kandasamy R; University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, UK., Egorova E; G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia., Ip M; Department of Microbiology, Chinese University of Hong Kong, Hong Kong, PR China., Breiman RF; The Emory Global Health Institute, Atlanta, USA., Klugman KP; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa.; Hubert Department of Global Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, GA, USA., McGee L; Centers for Disease Control and Prevention, Atlanta, USA., Bentley SD; Parasites and Microbes, Wellcome Sanger Institute, Hinxton, UK., von Gottberg A; National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service, Johannesburg, South Africa.; School of Pathology, University of the Witwatersrand, Johannesburg, South Africa., The Global Pneumococcal Sequencing Consortium; The Global Pneumococcal Sequencing Project (http://www.pneumogen.net/gps/.), UK.

Publikováno v: Microbial genomics [Microb Genom] 2022 Apr; Vol. 8 (4).

Oral Ulcers as an Unpredictable Adverse Reaction to Quetiapine Use in a Patient With Schizophrenia.

Autor: Srifuengfung M, Sukakul T, Pummangura C, Srifuengfung S, Viravan N

Publikováno v: Journal of clinical psychopharmacology [J Clin Psychopharmacol] 2022 Jan-Feb 01; Vol. 42 (1), pp. 103-106.